Citadel Advisors’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-30,083
| Closed | -$61.4K | – | 5809 |
|
|
2025
Q1 | $61.4K | Buy |
+30,083
| New | +$61.4K | ﹤0.01% | 5308 |
|
|
2023
Q1 | – | Sell |
-64
| Closed | -$411 | – | 5891 |
|
|
2022
Q4 | $411 | Buy |
+64
| New | +$411 | ﹤0.01% | 5960 |
|
|
2022
Q3 | – | Sell |
-944
| Closed | -$14K | – | 5840 |
|
|
2022
Q2 | $14K | Sell |
944
-2,910
| -76% | -$43.2K | ﹤0.01% | 5775 |
|
|
2022
Q1 | $143K | Sell |
3,854
-4,309
| -53% | -$160K | ﹤0.01% | 5477 |
|
|
2021
Q4 | $469K | Buy |
8,163
+2,066
| +34% | +$119K | ﹤0.01% | 4673 |
|
|
2021
Q3 | $623K | Buy |
6,097
+4,666
| +326% | +$477K | ﹤0.01% | 4293 |
|
|
2021
Q2 | $140K | Buy |
+1,431
| New | +$140K | ﹤0.01% | 5784 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6233 |
|
|
2020
Q4 | – | Sell |
-3,704
| Closed | -$1.78M | – | 5044 |
|
|
2020
Q3 | $1.78M | Sell |
3,704
-11,743
| -76% | -$5.65M | ﹤0.01% | 2384 |
|
|
2020
Q2 | $12M | Sell |
15,447
-615
| -4% | -$477K | ﹤0.01% | 993 |
|
|
2020
Q1 | $11.2M | Buy |
16,062
+611
| +4% | +$425K | 0.01% | 927 |
|
|
2019
Q4 | $14.2M | Buy |
+15,451
| New | +$14.2M | 0.01% | 987 |
|